跳至主要内容
临床试验/CTRI/2022/10/046227
CTRI/2022/10/046227招募中未知

EVALUATION OF EFFICACY OF TREATMENT REGIMEN CONSISTING OF VIRECHANA, NISHAKATAKADI KASHAYAM & GUDUCHI CHURNA TABLET IN THE MANAGEMENT OF JATOTTAR-PRAMEHA (DIABETES MELLITUS TYPE-2) - A RANDOMIZED CONTROLLED TRIA

Ministry of AYUSH Government of India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Individuals between the age of 16 to 70 years of either sex without any discrimination of cast and religion.
  • 2. Individuals suitable for Shodhana (Virechana) Procedure.
  • 3. Individuals with blood sugar fasting 126mg/dl to 200mg/dl and (or) post prandial plasma glucose level 200mg/dl to 275mg/dl
  • 4. Probably all such cases would be newly diagnoses cases of diabetes.
  • 5. Those who will sign the written informed consent.

排除标准

  • 1. Known case of Insulin Depended Diabetes Mellitus (IDDM).
  • 2. Individuals suffering from diseases like cancer, tuberculosis, sever cardiovascular diseases are other systemic diseases.
  • 3. Individuals suffering from other endocrinopathies like acromegaly, Cushingââ?¬•s syndrome.
  • 4. Individuals with genetic syndromes like Downââ?¬•s syndrome, Klinefelterââ?¬•s syndrome, Turnerââ?¬•s syndrome.
  • 5. Pregnant and lactating women.
  • 6. Any other condition which can jeopardise the outcome of the study will be excluded.

研究者

发起方
Ministry of AYUSH Government of India

相似试验